Related Experiment Video

Updated: May 8, 2026

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor
06:32

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor

Published on: May 2, 2025

Platelet reactivity tests for assessing antiplatelet drug response: what the clinician needs to know

Sabine Steiner1, Deddo Moertl

  • 1Department of Internal Medicine II, Division of Angiology, Medical University Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria. sabine.m.steiner@meduniwien.ac.at

Expert Review of Cardiovascular Therapy
|August 30, 2013
PubMed

Insights

Personalized antiplatelet therapy, guided by platelet function tests, aims to improve outcomes in cardiovascular disease. Tailoring treatment based on individual response can mitigate risks associated with antiplatelet medications like clopidogrel.

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Medicine

Background:

  • Antiplatelet therapy is crucial for preventing ischemic events in cardiovascular disease.
  • Platelet function testing offers insights into patient response to antiplatelet drugs.
  • Variability in platelet inhibition, particularly with clopidogrel, impacts clinical outcomes.

Purpose of the Study:

  • To review the current landscape of personalized antiplatelet therapy.
  • To discuss the role of platelet function testing in guiding treatment decisions.
  • To explore advancements in antiplatelet medications and their tailored application.

Main Methods:

  • Literature review of studies on antiplatelet therapy and platelet function testing.
  • Analysis of clinical, pharmacological, and genetic factors influencing drug response.
  • Evaluation of new antiplatelet agents (prasugrel, ticagrelor) and personalized treatment strategies.

Main Results:

  • High on-clopidogrel platelet reactivity is associated with adverse events, including stent thrombosis.
  • Newer agents like prasugrel and ticagrelor show potential to overcome clopidogrel limitations.
  • Platelet function testing supports the concept of tailoring antiplatelet therapy to individual patients.

Conclusions:

  • Personalized antiplatelet therapy holds promise for optimizing cardiovascular disease management.
  • Integrating platelet function testing into clinical practice can enhance treatment efficacy and safety.
  • Further research is needed to fully establish the benefits of tailored antiplatelet strategies.

More Related Videos

Microfluidics in Assessing Platelet Function06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Reproducibility and Harmonization in Research Using Biological Standards: The Example of Platelet Agonist Collagen-Related Peptide04:50

Reproducibility and Harmonization in Research Using Biological Standards: The Example of Platelet Agonist Collagen-Related Peptide

Published on: August 4, 2023

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...